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Abstract
Lack of expression of dystrophin leads to degeneration of muscle fibers and infiltration of connective and adipose tissue.
Cell transplantation therapy has been proposed as a treatment for intractable muscle degenerative disorders. Several
reports have demonstrated the ability of bone-marrow derived cells (BMDC) to contribute to non-haematopoietic tissues
including epithelium, heart, liver, skeletal muscle and brain following transplantation by means of fusion and
reprogramming. A key issue is the extent to which fusion and reprogramming can occur in vivo, particularly under
conditions of myogenic deterioration. To investigate the therapeutic potential of bone marrow transplantation in
monogenetic myopathy, green fluorescent protein-positive (GFP
+) bone marrow cells were transplanted into non-irradiated
c-kit receptor – deficient (W
41) mdx mice. This model allows BMDC reconstitution in the absence of irradiation induced
myeloablation. We provide the first report of BMDC fusion in a W
41/Dmd
mdx deficient mouse model. In the absence of
irradiation induced injury, few GFP
+ cardiomyocytes and muscle fibres were detected 24 weeks post BMT. It was expected
that the frequency of fusion in the hearts of W
41Dmd
mdx mice would be similar to frequencies observed in infarcted mice
[1]. Although, it is clear from this study that individual cardiomyocytes with monogenetic deficiencies can be rescued by
fusion, it is as clear that in the absence of irradiation, the formation of stable and reprogrammed fusion hybrids occurs, with
the current techniques, at very low levels in non-irradiated recipients.
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Introduction
Duchenne muscular dystrophy (DMD) is an X-linked recessive
disease characterized by mutations in the gene encoding the
membrane protein dystrophin. Lack of functional dystrophin leads
to degeneration of muscle fibres and infiltration of connective and
adipose tissue. Cell transplantation therapy has been proposed as a
treatment for intractable muscle degenerative disorders. Several
reports have demonstrated the ability of bone-marrow derived cells
(BMDC) to contribute to non-haematopoietic tissues including
epithelium, heart, liver, skeletal muscle and brain [1–10] following
transplantation by means of fusion and reprogamming [11]. A key
issue is the extent to which fusion and reprogramming can occur in
vivo, particularly under conditions of myogenic deterioration.
Previously the contribution of donor BMDC has been shown to
occur only in muscle regenerating after damage, and predomi-
nantly in irradiated host muscle [1,5,10]. Irradiation conditioning
impairs regeneration from endogenous myogenic precursors and
provides mitogenic conditions for donor myoblasts. Subsequently,
this ablation has a major impact on the incorporation of bone
marrow derived cells into the satellite cell compartment [12] and
muscle fibres. However, there remains much controversy pertain-
ing to the efficiency of transplanted BMDCs to fuse with recipient
tissue. Previous reports have demonstrated that 0.2–5% of total
muscle fibres are donor derived when irradiated mice are
transplanted with BMDC [5,12–14]. This rate of fusion remains
inordinately low to derive any clinical benefits from the symptoms
of DMD.
To investigate the therapeutic potential of bone marrow
transplantation in DMD, green fluorescent protein-positive
(GFP
+) bone marrow cells were transplanted into non-irradiated
c-kit receptor – deficient (W
41) mdx mice. This model of muscular
dystrophy allows BMDC reconstitution in the absence of
irradiation induced myeloablation [15] ensuring that potential
radiation induced fusion events do not contribute to our analyses.
We provide the first report of BMDC fusion in a W
41/Dmd
mdx
deficient mouse model. Although reconstitution efficiency was low,
bone marrow cells contributed to reprogrammed myocytes with
normal expression of dystrophin in skeletal muscle and myocar-
dium.
Materials and Methods
Mice
b-actin promoter driven GFP mice [16] were used as BM
donors. Haematopoietic deficient mice W
41/W
41 (ref 15) were
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mdx strain (Jackson
Laboratories). The amplification-resistant mutation assay (ARMS)
was used to genotype the Dmd
mdx mice [17]. Transgenic mice
were all on a C57Bl/6 (Taconic) background. All mice were 8–12
weeks old at the time of transplantation. Animal experiments were
performed with consent from the local ethics committee at Lund
University.
Transplantation
Whole un-fractionated bone marrow was transplanted by
intravenous (tail-vein) injection into non-irradiated adult W
41/
Dmd
mdx mice or sub-lethally irradiated (650 rad) W
41/Dmd
mdx
controls. Individual mice received 80610
6 cells. Haematopoietic
reconstitution was evaluated 8 weeks post transplantation and
prior to sacrifice by flow cytometry.
Anti-inflammatory treatment
Irradiated recipient W
41/Dmd
mdx mice were treated with
ciprofloxacin (125 mg/l) in drinking water to prevent irradiation
induced inflammation, starting from the day of irradiation [10].
Immunohistochemistry
Chimeric mice were sacrificed by cervical dislocation. Muscle
and heart tissue were perfused in situ, post fixed at 4uC with
Stefanini solution and equilibriated in 20% sucrose, frozen and
sectioned at 8–10 mm on a cryostat. Sections were stained with
primary antibodies to pan-haematopoietic CD45 (Neomarkers or
Abcam); cardiac troponin-T (cTNT) (Neomarkers); a-actinin
(Sigma); dystrophin (Abcam); GFP (Abcam,). Secondary antibod-
ies used were FITC donkey anti rabbit (Jackson Immunoresearch);
Alexa Fluor 555 goat anti mouse (Molecular Probes); Cy5 donkey
anti rat (Jackson Immunoresearch); Alexa Fluor 555 goat anti
rabbit (Molecular Probes); Alexa Fluor 488 donkey anti mouse
(Molecular Probes) all at pre-determined optimal concentrations.
DAPI was used to visualize nuclei. Immunofluorescense images
were captured using an Olympus BX51 (Olympus, Solna Sweden)
fluorescence microscope and a DP70 Olympus digital camera (DP
manager software Version 1.1.1.71) or a Zeisss Axiovert 200 M
microscope (Carl Zeiss, Go ¨ttingen, Germany) equipped with a
Zeiss ApoTome and a XB075 fluorescence lamp and a Zeiss
AxioCam MRm (Zeiss Axio Vision software).
Flow Cytometry
Blood samples were collected 8 weeks post transplantation and
again prior to sacrifice after 24 and 52 weeks respectively.
Peripheral blood was collected in heparinized eppendorff tubes
and mixed with PBS/1% FCS. Red blood cells were sedimented
and removed by Dextran 1:1 at 379C for 20–25 min. The cells
were washed with PBS/1% FCS and further stained with pre-
determined optimal concentrations of monoclonal mouse anti-
bodies on ice for 15 minutes. After washing the cells, samples were
resuspended in PBS/1% FCS and analyzed on a BD FACSCa-
libur. 7-amino actinomyosin (7-AAD) added prior to analysis to
exclude dead cells. The following monoclonal antibodies were
used for lineage readout: anti CD4-FITC, CD8-FITC, Gr-1-PE,
Mac-1-PE and B220-APC (all from BD Biosciences).
Evaluation and statistics
The frequency of GFP
+ donor-derived non-haematopoietic cells
in each tissue was determined by screening equal amounts of
sections from irradiated and non-irradiated W
41/Dmd
mdx mice.
Approximately 200,000 cardiomyocytes, 10,000 tibialis anterior
Figure 1. Validation of mouse model. Dystrophin phenotype in W
41/Dmd
mdx model assessed by IHC. Dystrophin localization in wild-type adult
myocardium (top left) and soleus muscle (bottom left). Aberant membrane dystrophin distribution in the heart (top right) and soleus (bottom right)
of deficient mice.
doi:10.1371/journal.pone.0027500.g001
Myogenic Reprogramming of Bone Marrow Cells
PLoS ONE | www.plosone.org 2 November 2011 | Volume 6 | Issue 11 | e27500and soleus muscle fibres per mouse were evaluated [10].
Frequency was calculated by dividing the total number of GFP
+
cells by the number of mice and the total number of cells analyzed
in each tissue. Data are presented as means 6 SD.
Results
To investigate bone marrow as a source for cell therapy without
exposing mice to irradiation, we used W
41Dmd
mdx double mutant
mice. In addition to muscular dystrophy, these mice are
haematopoietic deficient due to a genetically altered c-kit receptor.
Dystrophin membrane localization in W
41/Dmd
mdx mice was
ablated in comparison to WT expression in skeletal muscle and
myocardium (Figure 1). Next, W
41/Dmd
mdx mice were trans-
planted with GFP expressing bone-marrow cells. Irradiated W
41/
Dmd
mdx mice were used in control experiments. Eight weeks post
transplantation W
41Dmd
mdx recipients had stable donor-derived
blood reconstitution as determined by flow cytometry. GFP
+
reconstitution in the blood of un-irradiated recipients was
11.969.3% and 14.4614.2% at 24 and 52 weeks respectively
(Table 1). Irradiated control W
41Dmd
mdx recipients had higher
reconstitution at 66.4612.6% and 82.5610.6% at 24 and 52
weeks. Eighteen transplanted W
41Dmd
mdx were sacrificed at 24
weeks after transplantation and 20 recipients at 52 weeks to
evaluate GFP expression in tibialis anterior and soleus cross
sections. GFP
+ mononucleated cells were predominantly detected
in the muscle fibres of the non-irradiated group, including
interstitial cells and cells adhering to or associated with muscle
fibres and the lumen of vessels in myocardium (Figure S1).
Virtually all GFP
+ mononucleated cells were co-expressing pan-
haematopoietic marker CD45.
Chimeric skeletal muscle fibres were defined as GFP
+ a-actinin
+
CD45
neg. The distribution of GFP
+ myofibers was inherently low
in the skeletal muscles of W
41Dmd
mdx unconditioned mice with 15
and 9 fibres detected in all mice at 24 and 52 weeks respectively
(Figure 2a). Similarly, the hearts of recipient mice were also
screened for the presence of GFP
+ cTNT
+ CD45
neg cardiomyo-
cytes, of which only two events were recorded at 24 weeks post
BMT (Figure 2b). No chimeric myocytes were observed in the
hearts of recipients 52 weeks post BMT.
In contrast to non-irradiated W
41Dmd
mdx recipients, GFP
+
muscle fibres (Figure 3a); cardiomyocytes (Figure 3b) exhibiting
characteristic morphology and lineage marker expression were
discerned in the tissues of radiation conditioned W
41Dmd
mdx
recipients. These donor derived cells expressed dystrophin and a
total of 91 and 64 GFP
+ skeletal muscle fibres, 61 and 14 GFP
+
cardiomyocytes, were observed in all tissues 24 and 54 weeks after
transplantation respectively (Figure 3c–e).
Discussion
We sought to investigate BM contribution to myogenic lineages
in a steady-state disease model of dystrophin. Several requisite
conditions for BMDC conversion to the non-haematopoietic
compartment in this mouse model were present at the outset of
this study. Firstly, the ablation of endogenous bone marrow
environment by the presence of the W
41 mutation allowing donor
derived engraftment in the absence of irradiation damage.
Secondly, the exasperation for the need of regeneration induced
by Dmd
mdx tissue specific injury and subsequent demand on tissue
associated stem-cells, augmenting BMDC contribution. Neverthe-
less, the frequency of observed donor-derived muscle fibres and
cardiomyocytes detected in this study were too few to achieve any
functional restoration of dystrophin expression and subsequent
improvement of phenotype. Of the fusion events observed, re-
T
a
b
l
e
1
.
G
F
P
+
b
o
n
e
m
a
r
r
o
w
d
e
r
i
v
e
d
n
o
n
-
h
a
e
m
a
t
o
p
o
i
e
t
i
c
c
e
l
l
s
.
G
F
P
+
c
a
r
d
i
o
m
y
o
c
y
t
e
s
(
C
M
)
3
%
F
r
e
q
u
e
n
c
y
G
F
P
+
m
u
s
c
l
e
f
i
b
e
r
s
(
M
F
)
5
%
F
r
e
q
u
e
n
c
y
%
G
F
P
B
l
o
o
d
R
e
c
o
n
s
t
i
t
u
t
i
o
n
N
u
m
b
e
r
s
P
o
s
i
t
i
v
e
F
r
e
q
u
e
n
c
y
r
e
c
o
n
s
t
i
t
u
t
i
o
n
N
u
m
b
e
r
s
P
o
s
i
t
i
v
e
F
r
e
q
u
e
n
c
y
r
e
c
o
n
s
t
i
t
u
t
i
o
n
T
r
e
a
t
m
e
n
t
n
H
a
r
v
e
s
t
(
w
e
e
k
s
)
T
o
t
a
l
1
L
M
O
b
s
e
r
v
e
d
2
m
i
c
e
G
F
P
+
C
M
4
c
o
m
p
e
n
s
a
t
e
d
o
b
s
e
r
v
e
d
m
i
c
e
G
F
P
+
M
F
c
o
m
p
e
n
s
a
t
e
d
N
o
n
e
1
8
2
4
1
1
.
9
2
4
1
.
5
3
6
.
1
2
2
/
1
8
5
.
5
6
1
0
2
0
7
4
.
6
6
1
0
2
0
4
1
5
1
5
/
1
8
8
.
3
6
1
0
2
0
5
6
.
9
6
1
0
2
0
2
N
o
n
e
2
0
5
2
1
4
.
4
5
8
.
7
3
4
.
1
7
0
0
/
2
0
0
0
9
4
/
2
0
5
.
0
6
1
0
2
0
5
3
.
4
6
1
0
2
0
2
I
r
r
1
0
2
4
6
5
.
4
7
0
.
6
8
2
0
.
4
6
1
2
/
1
0
1
.
6
6
1
0
2
0
5
2
.
5
6
1
0
2
0
3
9
1
8
/
1
0
5
.
0
6
1
0
2
0
4
7
.
7
6
1
0
2
0
2
I
r
r
5
5
2
8
2
.
5
6
4
.
3
7
2
7
.
7
1
1
4
2
/
5
3
.
8
6
1
0
2
0
6
4
.
7
6
1
0
2
0
4
5
4
5
/
5
3
.
5
6
1
0
2
0
4
4
.
3
6
1
0
2
0
2
1
M
e
a
n
t
o
t
a
l
b
l
o
o
d
c
e
l
l
r
e
c
o
n
s
t
i
t
u
t
i
o
n
o
f
a
l
l
m
i
c
e
i
n
e
a
c
h
t
r
a
n
s
p
l
a
n
t
g
r
o
u
p
.
2
T
o
t
a
l
n
u
m
b
e
r
o
f
c
e
l
l
s
d
e
t
e
c
t
e
d
i
n
e
a
c
h
t
i
s
s
u
e
f
r
o
m
a
l
l
m
i
c
e
.
3
2
0
0
,
0
0
0
c
a
r
d
i
o
m
y
o
c
y
t
e
s
p
e
r
m
o
u
s
e
s
c
r
e
e
n
e
d
.
4
F
r
e
q
u
e
n
c
y
o
f
c
h
i
m
e
r
i
c
e
v
e
n
t
s
p
e
r
t
i
s
s
u
e
n
o
r
m
a
l
i
z
e
d
t
o
G
F
P
p
e
r
i
p
h
e
r
a
l
b
l
o
o
d
r
e
c
o
n
s
t
i
t
u
t
i
o
n
.
5
N
u
m
b
e
r
s
f
r
o
m
t
i
b
i
a
l
i
s
a
n
t
e
r
i
o
r
a
n
d
s
o
l
e
u
s
m
u
s
c
l
e
w
e
r
e
c
o
m
b
i
n
e
d
,
1
0
,
0
0
0
m
u
s
c
l
e
f
i
b
r
e
s
i
n
t
o
t
a
l
s
c
r
e
e
n
e
d
.
A
b
b
r
e
v
i
a
t
i
o
n
s
:
L
,
L
y
m
p
h
o
i
d
;
M
,
M
y
e
l
o
i
d
.
d
o
i
:
1
0
.
1
3
7
1
/
j
o
u
r
n
a
l
.
p
o
n
e
.
0
0
2
7
5
0
0
.
t
0
0
1
Myogenic Reprogramming of Bone Marrow Cells
PLoS ONE | www.plosone.org 3 November 2011 | Volume 6 | Issue 11 | e27500Figure 2. Evaluation of blood cell fusion with skeletal muscle fibres and cardiomyocytes in un-irradiated aged W
41/Dmd
mdx mice 24
weeks after bone marrow transplantation. GFP
+ (green, left panels) bone marrow derived cells expressing lineage markers (red, middle panels)
but not pan-haematopoietic CD45 (not shown). (a) GFP
+ a-actinin
+ CD45
2 soleus muscle fibers. (b) GFP
+ Cardiac Troponin-T
+ CD45
2 cardiomyocyte.
Scale bars represent 100 mm.
doi:10.1371/journal.pone.0027500.g002
Figure 3. Evaluation of blood cell fusion with skeletal muscle fibres and cardiomyocytes in sub-lethally irradiated W
41/Dmd
mdx mice
24 weeks after bone marrow transplantation. GFP
+ (green, left panels) bone marrow derived cells expressing lineage but not pan-
haematopoietic CD45 (not shown) and dystrophin re-expression. (a) GFP
+ a-actinin
+ CD45
2 soleus muscle fibres with dystrophin re-expression. (b)
GFP
+ Cardiac Troponin-T
+ CD45
2 cardiomyocyte with dystrophin re-expression. GFP
+ recipient peripheral blood reconstitution at 24 and 52 weeks
post BMT (c). Fused cells per tissue in non-irradiated (d) and irradiated recipients (e) at 24 and 52 weeks post BMT. Scale bars represent 50 mm. White
arrows indicate dystrophin membrane expression.
doi:10.1371/journal.pone.0027500.g003
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GFP
+ myocytes in skeletal muscle and myocardium.
It was hypothesized that the dystrophic phenotype would
worsen with age and that the frequency of BMDC muscle
reconstitution would increase accordingly, however no correlation
between worsening phenotype and improved engraftment was
observed. Fusion events in both skeletal muscle and myocardium
were extraordinarily rare under the normal pathological condi-
tions of muscular dystrophy in this model. In the absence of
irradiation induced injury, only two GFP
+ cardiomyocytes and
fifteen GFP
+ muscle fibres were detected 24 weeks post BMT. It
was expected that the frequency of fusion in the hearts of
W
41Dmd
mdx mice would be similar to frequencies observed in
infarcted mice [1]. However, our data indicate that the percentage
frequency of fusion events between irradiated and non-irradiated
tissues are similar in both skeletal muscle and heart, when
compensated for the frequency of GFP
+ blood cell reconstitution
(Table 1).
It is clear from these results that in the absence of irradiation,
the formation of stable and reprogrammed fusion hybrids occurs
at extremely low or undetectable levels in non-irradiated
recipients. The cardiac muscle degeneration associated with the
dystrophic phenotype was inadequate pre-conditioning for the
recruitment of BMDCs and failed to trigger physiological
mechanisms such as local inflammation [10], mobilisation and
homing of hematopoietic cells. It is likely that the relatively mild
muscle degeneration in the Dmd
mdx mouse model [18–19] in
comparison with DMD patients contributes to the low frequency
of BMDC engraftment observed. Also, the functional requirement
of dystrophin to transmit muscle force is far less in mice than
humans. Exercise induced destruction, correlative with irradiation
damage, has been shown to enhance the contribution of GFP
+
bone marrow derived cells to the myogenic phenotype in the
Dmd
mdx model [12]. Similarly, in studies of other tissues such as
liver, irradiation was necessary for BMDC conversion to liver [20–
21], but in conjunction with chemical or genetic damage-inducing
discriminating pressures [3,5,7].
Supporting Information
Figure S1 Mononucleated GFP+ cells co-express CD45
and are confined predominantly to the interstitial
cavities and vessels in un-irradiated tissue. Myocardium
of W
41/Dmd
mdx mouse 24 weeks post transplantation. Cardiomy-
ocytes stained with c-Troponin-T (top left panel), and DAPI (top
right panel) GFP and CD45 co-localization (bottom left and
bottom right panel.). Scale bars represent 100 mm.
(TIF)
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